SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

Developed using the Company’s proprietary informatics and design workflow, NK.SET is a synthetic promoter library designed to enable precise, tuneable gene expression in natural killer (NK) cell immunotherapies, to improve both efficacy and targeting

← Previous
Next →
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY

© 2026 All rights Reserved. Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.